| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6117292 | Immunology Letters | 2014 | 7 Pages |
Abstract
These findings suggest that the therapeutic effect of rosiglitazone in neutrophilic asthma is partially due to the role of the PPARγ pathway in regulating T cell proliferation and differentiation.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Zhao Yan, Huang Yi, He Jing, Li Changyi, Deng Wang, Ran Xuemei, Wang Daoxin,